Cargando…
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
BACKGROUND: The human leucine-rich, repeat-containing G protein-coupled receptor 5 (LGR5) is a stem cell marker in numerous adult tissues and is overexpressed in a large number of human carcinoma including colon cancer, breast cancer and oral squamous cell carcinomas (OSCC). The role of the full len...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377725/ https://www.ncbi.nlm.nih.gov/pubmed/30770730 http://dx.doi.org/10.1186/s12885-019-5327-8 |
_version_ | 1783395801037275136 |
---|---|
author | Rot, Swetlana Kaune, Tom Taubert, Helge Greither, Thomas Kotrba, Johanna Güttler, Antje Wichmann, Henri Bilkenroth, Udo Wienke, Andreas Al-Nawas, Bilal Bache, Matthias Vordermark, Dirk Wickenhauser, Claudia Bethmann, Daniel Eckert, Alexander W. Kappler, Matthias |
author_facet | Rot, Swetlana Kaune, Tom Taubert, Helge Greither, Thomas Kotrba, Johanna Güttler, Antje Wichmann, Henri Bilkenroth, Udo Wienke, Andreas Al-Nawas, Bilal Bache, Matthias Vordermark, Dirk Wickenhauser, Claudia Bethmann, Daniel Eckert, Alexander W. Kappler, Matthias |
author_sort | Rot, Swetlana |
collection | PubMed |
description | BACKGROUND: The human leucine-rich, repeat-containing G protein-coupled receptor 5 (LGR5) is a stem cell marker in numerous adult tissues and is overexpressed in a large number of human carcinoma including colon cancer, breast cancer and oral squamous cell carcinomas (OSCC). The role of the full length transcript (LGR5FL) in progression and prognosis of several cancers was reported. However, the biological function of three splice variants of LGR5 (LGR5Δ5, LGR5Δ8 and LGR5Δ5–8) has yet to be thoroughly investigated. METHODS: Seventy-eight frozen tumor samples from adult OSCC patients were studied using quantitative real-time TaqMan™ PCR analysis. The mRNA levels of full length LGR5, the splice variant of LGR5 lacking exon 5 (LGR5Δ5), the splice variant of LGR5 lacking exon 8 (LGR5Δ8) and the mRNA level of all known transcript variants together (LGR5all) were quantified and correlated to overall and disease-specific survival of OSCC patients, clinical parameters and the mRNA level of different tumor-associated markers. RESULTS: An elevated level of tumoral LGR5Δ5 mRNA, but not LGR5FL, LGR5Δ8 or LGR5all mRNA was significantly associated with a poor prognosis for the overall and disease-specific survival of OSCC patients (hazard ratio (HR) = 2.0; p = 0.02; 95% CI: 1.1–3.7; HR = 3.2; p = 0.01; 95% CI: 1.3–8.0; multivariable Cox regression), respectively. Additionally, a higher tumoral level of LGR5Δ5 mRNA in primary tumors was associated with the occurrence of regional lymph node metastases in OSCC patients (odds ratio (OR) = 3.1; p = 0.022; 95% CI: 1.2–7.9; binary logistic regression). Furthermore, the mRNA levels of all investigated LGR5 transcript variants were significantly correlated with the mRNA expression of Wnt-target genes and markers of epithelial-to-mesenchymal transition (EMT). CONCLUSION: The mRNA level of the LGR5 splice variant LGR5Δ5 is an independent negative prognostic marker for overall and disease-specific survival and metastasis in OSCC patients. Additionally, we suggest, all LGR5 transcript variants are involved in the EMT process mainly through activating the Wnt-signalling pathway. |
format | Online Article Text |
id | pubmed-6377725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63777252019-02-27 Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients Rot, Swetlana Kaune, Tom Taubert, Helge Greither, Thomas Kotrba, Johanna Güttler, Antje Wichmann, Henri Bilkenroth, Udo Wienke, Andreas Al-Nawas, Bilal Bache, Matthias Vordermark, Dirk Wickenhauser, Claudia Bethmann, Daniel Eckert, Alexander W. Kappler, Matthias BMC Cancer Research Article BACKGROUND: The human leucine-rich, repeat-containing G protein-coupled receptor 5 (LGR5) is a stem cell marker in numerous adult tissues and is overexpressed in a large number of human carcinoma including colon cancer, breast cancer and oral squamous cell carcinomas (OSCC). The role of the full length transcript (LGR5FL) in progression and prognosis of several cancers was reported. However, the biological function of three splice variants of LGR5 (LGR5Δ5, LGR5Δ8 and LGR5Δ5–8) has yet to be thoroughly investigated. METHODS: Seventy-eight frozen tumor samples from adult OSCC patients were studied using quantitative real-time TaqMan™ PCR analysis. The mRNA levels of full length LGR5, the splice variant of LGR5 lacking exon 5 (LGR5Δ5), the splice variant of LGR5 lacking exon 8 (LGR5Δ8) and the mRNA level of all known transcript variants together (LGR5all) were quantified and correlated to overall and disease-specific survival of OSCC patients, clinical parameters and the mRNA level of different tumor-associated markers. RESULTS: An elevated level of tumoral LGR5Δ5 mRNA, but not LGR5FL, LGR5Δ8 or LGR5all mRNA was significantly associated with a poor prognosis for the overall and disease-specific survival of OSCC patients (hazard ratio (HR) = 2.0; p = 0.02; 95% CI: 1.1–3.7; HR = 3.2; p = 0.01; 95% CI: 1.3–8.0; multivariable Cox regression), respectively. Additionally, a higher tumoral level of LGR5Δ5 mRNA in primary tumors was associated with the occurrence of regional lymph node metastases in OSCC patients (odds ratio (OR) = 3.1; p = 0.022; 95% CI: 1.2–7.9; binary logistic regression). Furthermore, the mRNA levels of all investigated LGR5 transcript variants were significantly correlated with the mRNA expression of Wnt-target genes and markers of epithelial-to-mesenchymal transition (EMT). CONCLUSION: The mRNA level of the LGR5 splice variant LGR5Δ5 is an independent negative prognostic marker for overall and disease-specific survival and metastasis in OSCC patients. Additionally, we suggest, all LGR5 transcript variants are involved in the EMT process mainly through activating the Wnt-signalling pathway. BioMed Central 2019-02-15 /pmc/articles/PMC6377725/ /pubmed/30770730 http://dx.doi.org/10.1186/s12885-019-5327-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Rot, Swetlana Kaune, Tom Taubert, Helge Greither, Thomas Kotrba, Johanna Güttler, Antje Wichmann, Henri Bilkenroth, Udo Wienke, Andreas Al-Nawas, Bilal Bache, Matthias Vordermark, Dirk Wickenhauser, Claudia Bethmann, Daniel Eckert, Alexander W. Kappler, Matthias Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients |
title | Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients |
title_full | Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients |
title_fullStr | Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients |
title_full_unstemmed | Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients |
title_short | Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients |
title_sort | prognostic impact of mrna levels of lgr5 transcript variants in oscc patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377725/ https://www.ncbi.nlm.nih.gov/pubmed/30770730 http://dx.doi.org/10.1186/s12885-019-5327-8 |
work_keys_str_mv | AT rotswetlana prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT kaunetom prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT tauberthelge prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT greitherthomas prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT kotrbajohanna prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT guttlerantje prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT wichmannhenri prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT bilkenrothudo prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT wienkeandreas prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT alnawasbilal prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT bachematthias prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT vordermarkdirk prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT wickenhauserclaudia prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT bethmanndaniel prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT eckertalexanderw prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients AT kapplermatthias prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients |